BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25616574)

  • 1. Hematopoiesis specific loss of Cdk2 and Cdk4 results in increased erythrocyte size and delayed platelet recovery following stress.
    Jayapal SR; Wang CQ; Bisteau X; Caldez MJ; Lim S; Tergaonkar V; Osato M; Kaldis P
    Haematologica; 2015 Apr; 100(4):431-8. PubMed ID: 25616574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation.
    Berthet C; Klarmann KD; Hilton MB; Suh HC; Keller JR; Kiyokawa H; Kaldis P
    Dev Cell; 2006 May; 10(5):563-73. PubMed ID: 16678773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice thrive without Cdk4 and Cdk2.
    Barrière C; Santamaría D; Cerqueira A; Galán J; Martín A; Ortega S; Malumbres M; Dubus P; Barbacid M
    Mol Oncol; 2007 Jun; 1(1):72-83. PubMed ID: 19383288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A confederacy of kinases: Cdk2 and Cdk4 conspire to control embryonic cell proliferation.
    Hinds PW
    Mol Cell; 2006 May; 22(4):432-3. PubMed ID: 16713571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
    Ando K; Griffin JD
    Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition.
    Li W; Kotoshiba S; Berthet C; Hilton MB; Kaldis P
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):486-91. PubMed ID: 19129496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.
    Gillam MP; Nimbalkar D; Sun L; Christov K; Ray D; Kaldis P; Liu X; Kiyokawa H
    Oncogene; 2015 Feb; 34(7):932-8. PubMed ID: 24531709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.
    Padmakumar VC; Aleem E; Berthet C; Hilton MB; Kaldis P
    Mol Cell Biol; 2009 May; 29(10):2582-93. PubMed ID: 19307310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Cdk2 and Cdk4 induces a switch from proliferation to differentiation in neural stem cells.
    Lim S; Kaldis P
    Stem Cells; 2012 Jul; 30(7):1509-20. PubMed ID: 22532528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases.
    Barbacid M; Ortega S; Sotillo R; Odajima J; Martín A; Santamaría D; Dubus P; Malumbres M
    Cold Spring Harb Symp Quant Biol; 2005; 70():233-40. PubMed ID: 16869759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal Schwann cell proliferation but not myelination is strictly and uniquely dependent on cyclin-dependent kinase 4 (cdk4).
    Atanasoski S; Boentert M; De Ventura L; Pohl H; Baranek C; Beier K; Young P; Barbacid M; Suter U
    Mol Cell Neurosci; 2008 Mar; 37(3):519-27. PubMed ID: 18191580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited redundancy in phosphorylation of retinoblastoma tumor suppressor protein by cyclin-dependent kinases in acute lymphoblastic leukemia.
    Schmitz NM; Hirt A; Aebi M; Leibundgut K
    Am J Pathol; 2006 Sep; 169(3):1074-9. PubMed ID: 16936279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
    Chen B; Pollard JW
    Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
    Moore GD; Ayabe T; Kopf GS; Schultz RM
    Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.